Professor Samreen Ahmed retweeted
Great day @RCPhysicians for a lung oncology training meeting. Brilliant speakers and discussions in an exciting field. Thanks @tnewsomdavis @ProfSIAhmed and @Boehringer_UKI
AddThis | Home authors.elsevier.com/sd/arti…
This is a really interesting Medical Student perspective. Very important for the future of Medical Oncology
Professor Samreen Ahmed retweeted
BTOG is 20 this year! In our latest 'BTOG Does...' podcast @tnewsomdavis
talks to @DrSanjayPopat about 20 years of BTOG. Listen at btog.org/resources/btog… #btogpodcast
Professor Samreen Ahmed retweeted
Replying to @tnewsomdavis
Thanks @tnewsomdavis. There’s some really good resources out there to demistify genomics. Hope I highlighted a few to @BTOGORG members. Forgot to mention make sure drivers documented in your diagnosis list. It may not be targetable now but #lcsm drug development moves quickly
Professor Samreen Ahmed retweeted
Congratulations @drMaryOBr
Lifetime Achievement Award 🥇
👏 👏👏
#BTOG22
Professor Samreen Ahmed retweeted
📢 The ACP will host a best of @SABCSSanAntonio UK virtual session w/ the most significant advances in #breastcancer treatment in 2022
Chaired by @ProfSIAhmed and Dr Caroline Archer
Date: Mon 31st Jan 22
Time: 18:30 (GMT)
FREE for all... register now: oncologyeducation.com/events…
Professor Samreen Ahmed retweeted
We are pleased to have appointed five subject specialists to the Expert Panel to aid the evaluation of cancer services pledges:
🔹Professor Samreen Ahmed
🔹Professor Janet E Brown
🔹Dr Jeanette Dixon
🔹Nikki Morris
🔹Minesh Patel
Read more:
ukparliament.shorthandstorie…
Professor Samreen Ahmed retweeted
Here's a round up of the stats from our hugely successful, virtual annual conference #BTOG21 We're delighted to have reached so many people and shared so much expert knowledge. @DrSanjayPopat @tnewsomdavis
Professor Samreen Ahmed retweeted
Don’t miss our upcoming post-#BTOG21 #LungCancer roundtable! Register now!
19 May at 7pm CEST/1pm EDT
The panel features @DrSanjayPopat @LungConsultant, @ProfSIAhmed & @DavidGilligan10!
@BTOGORG #LCsm #OncoAlert
Professor Samreen Ahmed retweeted
Tonight - 6pm. Great speakers reflecting on the last year and what we have learnt. Free for all on RCP Player. @PWMJohnson @AggarwalOnc @katiespencer72 @onctrainees @ACPUK
We've teamed up with @RCPLondon and @ACPUK to organise an evening webinar on the impact of #COVID19 on #cancer care.
Taking place at 18:00 on 11 May, it features the RCR's @tomroques alongside a host of leading oncologists.
Find out more👉bit.ly/2RCfdM0
Professor Samreen Ahmed retweeted
Discussion with @DrSanjayPopat @ProfSIAhmed @DavidGilligan10 on current lung cancer issues and highlights from a fantastic (but different) #BTOG21
Looking forward to the final edit @VJOncology
Well done Dan @DrDanielJHughes: poster prize winner. Fantastic poster on PETCT and PDL1 correlation.@ACPUK @BTOGORG
#BTOG21 Very nice presentation from Dr Milner-Watts. Reassuring and reliable detection of Tier 1 variants on G360
Professor Samreen Ahmed retweeted
One week today is the start of our 19th annual conference, #BTOG21. Have you registered to join us yet? btog.org/btog-events/annual-… #LungCancer #LCSM @DrSanjayPopat
Professor Samreen Ahmed retweeted
Free registration for healthcare professionals for the 19th BTOG Annual Conference 2021 – BTOG | British Thoracic Oncology Group.
UK’s top lung cancer conference! #btog21 #radonc #lcsm btog.org/btog-events/annual-…
Professor Samreen Ahmed retweeted
Don't forget to register for our next webinar on #cancer #Genomics, Tues 20th April, 6pm
with the wonderful @McVeighTerri of @royalmarsdenNHS and Dr Ellen Copson @unisouthampton
With an intro to @GenomicsEngland GENotes from @DrAllyCat
Register now: theacp.org.uk/calendar1/acp-…
Professor Samreen Ahmed retweeted
19th BTOG Annual Conference, 22-23 April 2021.
Free registration for all healthcare professionals, advocates, patient organisations and charities.
More info here: btog.org/btog-events/annual-…
#lungcancer #manyfacesonevoice #BTOG2021 @BTOGORG
Professor Samreen Ahmed retweeted
Today at #AACR21 I was honored to present results of the phase 3 CheckMate 816 neoadjuvant chemo-nivo lung cancer trial on behalf of all the colleagues, patients & families who made it possible. In this thread I will discuss why we did the study, results and next steps/


























